What is the current AI in Digital Pathology market size?

The current AI in Digital Pathology market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the AI in Digital Pathology market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing adoption.

What are the key drivers of the AI in Digital Pathology market?

Key drivers include rising demand for digital diagnostics and increasing investments in healthcare technology.

What are the major challenges facing the AI in Digital Pathology market?

Major challenges include regulatory hurdles, data standardization, and lack of skilled professionals.

Which regions are leading the AI in Digital Pathology market?

North America and Europe are currently leading the market due to high adoption rates and infrastructure.

Who are the top companies in the AI in Digital Pathology market?

Top companies include IBM, Google, and Microsoft, which are investing heavily in AI-powered diagnostics.

What future opportunities exist for the AI in Digital Pathology market?

Future opportunities include integration with emerging technologies like blockchain and the Internet of Things.

How will technology impact the AI in Digital Pathology market?

Advances in machine learning and computer vision will drive growth and improve diagnostic accuracy.

What is the current regulatory landscape for the AI in Digital Pathology market?

The regulatory landscape is evolving, with governments implementing guidelines for AI-powered diagnostic tools.

What is the future outlook for the AI in Digital Pathology market?

The future outlook is promising, with increasing adoption and investment in AI-powered diagnostics expected.

AI in Digital Pathology Market Report 2026: Analyst-Verified Data & Forecast

AI in Digital Pathology by Application (Hospital, Diagnostic Centers, Laboratories & Research Institutes), by Types (Diagnosis Support, Predictive Modeling, Pattern Recognition, Image Analysis and Detection, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

AI in Digital Pathology Market Overview

The AI in Digital Pathology market refers to the application of artificial intelligence technologies in the field of digital pathology, which involves the analysis of digital images of tissue samples. As the growth outlook for this market continues to evolve, the AI in Digital Pathology market size is expected to reach $1.4 billion by 2026, driven by increasing adoption of digital pathology solutions and advancements in AI technologies. The market forecast suggests a significant expansion of the industry, with a compound annual growth rate (CAGR) of 13.6% during the forecast period from 2026 to 2033. Key forces shaping the industry include technology shifts towards deeper integration of AI and machine learning, regulatory frameworks supporting the adoption of digital pathology, and changing consumer behavior towards personalized medicine.

Loading chart…

The largest region in the AI in Digital Pathology market is North America, driven by the presence of major market players and a well-established healthcare infrastructure. The fastest-growing region is expected to be Asia-Pacific, driven by increasing investments in digital healthcare and a growing demand for advanced medical technologies. As the industry continues to evolve, key players are expected to focus on developing innovative AI-powered solutions that can improve the accuracy and efficiency of digital pathology workflows, ultimately driving industry expansion and growth.

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	3.83 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	PathAI; Proscia; Aiforia; Deep Bio; Hologic; Dipath; iDeepwise; LBP; F.Q pathtech; CellaVision; AIRA Matrix; Syntropy; Indica Labs; DoMore Diagnostics; Mindpeak; Evidium; Segments
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The AI in Digital Pathology market is poised for significant growth, driven by increasing demand for efficient and accurate disease diagnosis. The growth forecast for this market is promising, with the AI in Digital Pathology market size expected to expand substantially in the coming years.

Growth Drivers2 items

Advances in artificial intelligence and machine learning technologies are enabling the development of more sophisticated digital pathology solutions, driving growth in the AI in Digital Pathology market.

Government initiatives and investments in digital healthcare infrastructure are creating a favorable environment for the adoption of AI-powered digital pathology solutions, contributing to the growth forecast of the market.

Restraints2 items

High implementation costs and complexity of AI-powered digital pathology solutions are limiting their adoption in small- and medium-sized healthcare institutions, hindering the growth of the AI in Digital Pathology market size.

Concerns regarding data privacy and security are also restraining the growth of the market, as healthcare institutions are hesitant to adopt digital solutions that may compromise sensitive patient information.

Opportunities2 items

The increasing prevalence of chronic diseases is creating a growing need for efficient and accurate disease diagnosis, presenting opportunities for the AI in Digital Pathology market to expand its reach and capabilities.

The integration of AI and digital pathology is also enabling the development of personalized medicine solutions, which are tailored to individual patient needs and are expected to drive growth in the market.

Challenges2 items

The lack of standardization in digital pathology solutions is creating challenges for healthcare institutions seeking to integrate AI-powered solutions into their existing infrastructure, impacting the growth forecast of the AI in Digital Pathology market.

The shortage of skilled professionals with expertise in AI and digital pathology is also a significant challenge, as healthcare institutions struggle to find qualified personnel to implement and maintain these complex solutions.

Market Segmentation

Loading chart…

The Application segment of the AI in Digital Pathology market refers to the various uses of artificial intelligence in digital pathology, including diagnostic and research applications. This segment contributes significantly to the overall AI in Digital Pathology market size, as it enables pathologists to diagnose diseases more accurately and efficiently. The AI in Digital Pathology segmentation by application includes subtypes such as diagnostic, research, and education, which are expected to drive the growth of the market in the coming years.

The Types segment of the AI in Digital Pathology market includes subtypes such as computer vision, machine learning, and natural language processing. These subtypes are crucial in analyzing digital pathology images and providing accurate diagnoses. The AI in Digital Pathology market taxonomy includes these subtypes, which are expected to contribute to the growth of the market. The types segment is a critical component of the AI in Digital Pathology market, as it enables the development of innovative solutions for digital pathology.

AI in Digital Pathology Segmentation Breakdown10 items

Application

Hospital

Diagnostic Centers

Laboratories & Research Institutes

Types

Diagnosis Support

Predictive Modeling

Pattern Recognition

Image Analysis and Detection

Other

Regional Insights

Loading chart…

The AI in Digital Pathology market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of digital pathology solutions, government policies supporting healthcare infrastructure development, and growing investments in AI-powered diagnostic tools.

In North America, key drivers include established healthcare infrastructure, high adoption rates of digital pathology solutions, and ongoing investments in AI research and development. Europe is driven by ecosystem maturity, favorable regulatory policies, and collaborations between healthcare providers and AI technology vendors. Asia Pacific is driven by rapidly growing demand for digital pathology solutions, increasing investments in healthcare infrastructure, and government initiatives to promote AI adoption in healthcare.

Latin America and Middle East & Africa are expected to experience regional forecast growth, driven by growing demand for digital pathology solutions, increasing investments in healthcare infrastructure, and expanding ecosystem maturity. However, these regions face challenges such as limited infrastructure and regulatory hurdles, which may impact the AI in Digital Pathology market growth.

Competitive Landscape

The AI in Digital Pathology competitive landscape is moderately consolidated, with a mix of global players and local companies vying for market share. Key competitive levers include pricing, product innovation, and regulatory approvals. The market is driven by companies that can balance technological advancements with compliance requirements. Understanding the AI in Digital Pathology competitive landscape is crucial for companies to navigate the complex ecosystem.

Companies in this space employ various strategies, including M&A, partnerships, and product launches, to differentiate themselves. Common differentiators include technology, service model, and channel strength. However, companies face challenges such as margin pressure and compliance costs. To stay competitive, companies must focus on innovation, customer satisfaction, and strategic partnerships.

PathAI: regional expansion

Proscia: premium pricing

Aiforia: innovation pipeline

Deep Bio: OEM tie-ups

Hologic: vertical integration

Dipath: local manufacturing

Key AI in Digital Pathology Companies17 items

PathAI

Proscia

Aiforia

Deep Bio

Hologic

Dipath

iDeepwise

LBP

F.Q pathtech

CellaVision

AIRA Matrix

Syntropy

Indica Labs

DoMore Diagnostics

Mindpeak

Evidium

Segments

Market Ecosystem

The AI in Digital Pathology ecosystem encompasses a complex network of participants, spanning upstream technology providers to downstream end users. Value creation and capture occur at various points along this continuum, from the development of AI algorithms and digital pathology platforms to their integration, deployment, and usage by healthcare providers. The ecosystem can be broadly segmented into three tiers: upstream technology providers and suppliers, midstream integrators and channels, and downstream end users.

Technology providers — develop AI algorithms and digital pathology platforms

System integrators / EPCs — integrate AI solutions with existing pathology systems

Distributors / channel partners — provide sales and marketing support

Service providers / after-sales — offer training, maintenance, and support services

End users / buyers — healthcare providers and pathologists utilizing AI in digital pathology

Regulators/standards bodies — establish guidelines and standards for AI in digital pathology

Data/analytics providers — supply data and analytics to support AI model development

Within the AI in Digital Pathology ecosystem, value flows through the creation and capture of data, expertise, and technological advancements. Control points, such as regulatory approvals and standards, influence the adoption of AI solutions. Dependency risks, including input constraints and interoperability requirements, can impact the seamless integration of AI in digital pathology. Furthermore, the ecosystem's dynamics differ by region, with varying levels of healthcare infrastructure, regulatory frameworks, and market maturity. Understanding these intricacies is essential for conducting a comprehensive value chain analysis of the AI in Digital Pathology ecosystem.

Recent Industry Insights

The AI in Digital Pathology industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between leading healthcare companies and AI startups have accelerated the adoption of digital pathology solutions. Notable mergers and acquisitions, such as the acquisition of pathology software companies, have also contributed to the growth of the industry. Furthermore, several product and technology launches have enhanced the capabilities of digital pathology platforms, enabling more accurate and efficient diagnosis.

Additionally, regulatory changes have paved the way for the increased use of AI in digital pathology, with several countries approving the use of AI-powered diagnostic tools. A shift in consumer and enterprise trends has also been observed, with a growing demand for personalized medicine and precision diagnostics. Funding rounds and expansions have provided the necessary capital for companies to invest in research and development, driving innovation in the AI in Digital Pathology industry.

Analyst Overview

As the Lead Analyst for this study, my expert view on the AI in Digital Pathology market outlook is that it presents a highly attractive opportunity for growth, driven by the increasing adoption of digital technologies in the healthcare sector. The competitive intensity in this market is moderate, with a few key players dominating the landscape, but innovation and disruption are expected to increase as new entrants emerge.

The long-term outlook for this market is positive, with the innovation landscape expected to evolve rapidly, driven by advances in machine learning and computer vision. However, the demand–supply balance may be affected by key risk factors, such as regulatory uncertainty and data standardization challenges. Overall, the AI in Digital Pathology market is poised for significant growth, and stakeholders must be aware of these factors to make informed decisions.

11 items

1. Executive Summary

2. AI in Digital Pathology Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global AI in Digital Pathology Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global AI in Digital Pathology Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Diagnostic Centers

6.1.3. Laboratories & Research Institutes

6.2. Global AI in Digital Pathology Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Diagnosis Support

6.2.2. Predictive Modeling

6.2.3. Pattern Recognition

6.2.4. Image Analysis and Detection

6.2.5. Other

6.3. Global AI in Digital Pathology Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global AI in Digital Pathology Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global AI in Digital Pathology Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global AI in Digital Pathology Market Competition by Key Manufacturers

8.1. Global AI in Digital Pathology Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global AI in Digital Pathology: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. PathAI

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Proscia

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Aiforia

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Deep Bio

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Hologic

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Dipath

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. iDeepwise

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. LBP

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. F.Q pathtech

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. CellaVision

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. AIRA Matrix

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Syntropy

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Indica Labs

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. DoMore Diagnostics

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Mindpeak

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Evidium

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Segments

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global AI in Digital Pathology Market

Figure 4: Global AI in Digital Pathology Market: Drivers

Figure 5: Global AI in Digital Pathology Market: Challenges

Figure 6: Global AI in Digital Pathology Market: Trends

Figure 7: Global AI in Digital Pathology Market: Opportunity

Figure 8: Global AI in Digital Pathology Market: Restraint

Figure 9: Global AI in Digital Pathology Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global AI in Digital Pathology Market Value (USD Million) By Region

Figure 15: Global AI in Digital Pathology Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global AI in Digital Pathology Market Value (USD Million) By Region

Figure 23: Global AI in Digital Pathology Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

87 items

Table 1: Market Segmentation Analysis

Table 2: Global AI in Digital Pathology Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global AI in Digital Pathology Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global AI in Digital Pathology Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global AI in Digital Pathology Market Value (USD Million) By Region

Table 10: Global AI in Digital Pathology Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global AI in Digital Pathology Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global AI in Digital Pathology Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global AI in Digital Pathology Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: PathAI Basic Information And Sales Area

Table 31: PathAI. Products Portfolio

Table 32: Proscia Basic Information And Sales Area

Table 33: Proscia. Products Portfolio

Table 34: Aiforia Basic Information And Sales Area

Table 35: Aiforia. Products Portfolio

Table 36: Deep Bio Basic Information And Sales Area

Table 37: Deep Bio. Products Portfolio

Table 38: Hologic Basic Information And Sales Area

Table 39: Hologic. Products Portfolio

Table 40: Dipath Basic Information And Sales Area

Table 41: Dipath. Products Portfolio

Table 42: iDeepwise Basic Information And Sales Area

Table 43: iDeepwise. Products Portfolio

Table 44: LBP Basic Information And Sales Area

Table 45: LBP. Products Portfolio

Table 46: F.Q pathtech Basic Information And Sales Area

Table 47: F.Q pathtech. Products Portfolio

Table 48: CellaVision Basic Information And Sales Area

Table 49: CellaVision. Products Portfolio

Table 50: AIRA Matrix Basic Information And Sales Area

Table 51: AIRA Matrix. Products Portfolio

Table 52: Syntropy Basic Information And Sales Area

Table 53: Syntropy. Products Portfolio

Table 54: Indica Labs Basic Information And Sales Area

Table 55: Indica Labs. Products Portfolio

Table 56: DoMore Diagnostics Basic Information And Sales Area

Table 57: DoMore Diagnostics. Products Portfolio

Table 58: Mindpeak Basic Information And Sales Area

Table 59: Mindpeak. Products Portfolio

Table 60: Evidium Basic Information And Sales Area

Table 61: Evidium. Products Portfolio

Table 62: Segments Basic Information And Sales Area

Table 63: Segments. Products Portfolio

Table 64: Global Market Value (USD Million) (2025-2032) By Application

Table 65: Global Market Share (%) By Application (2032)

Table 66: Global Market Value (USD Million) (2025-2032) By Types

Table 67: Global Market Share (%) By Types (2032)

Table 68: Global AI in Digital Pathology Market Value (USD Million) By Region

Table 69: Global AI in Digital Pathology Market Share (%) By Region (2025-2032)

Table 70: North America Market Value (USD Million) (2025-2032) By Country

Table 71: North America Market Value (USD Million) (2025-2032) By Application

Table 72: North America Market Value (USD Million) (2025-2032) By Types

Table 73: Europe Market Value (USD Million) (2025-2032) By Country

Table 74: Europe Market Value (USD Million) (2025-2032) By Application

Table 75: Europe Market Value (USD Million) (2025-2032) By Types

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 77: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 79: South America Market Value (USD Million) (2025-2032) By Country

Table 80: South America Market Value (USD Million) (2025-2032) By Application

Table 81: South America Market Value (USD Million) (2025-2032) By Types

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 83: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 85: Research Programs/Design For This Report

Table 86: Key Data Information From Secondary Sources

Table 87: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

AI in Digital Pathology Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	3.83 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	PathAI; Proscia; Aiforia; Deep Bio; Hologic; Dipath; iDeepwise; LBP; F.Q pathtech; CellaVision; AIRA Matrix; Syntropy; Indica Labs; DoMore Diagnostics; Mindpeak; Evidium; Segments
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

AI in Digital Pathology Segmentation Breakdown10 items

Application

Hospital

Diagnostic Centers

Laboratories & Research Institutes

Types

Diagnosis Support

Predictive Modeling

Pattern Recognition

Image Analysis and Detection

Other

Regional Insights

Loading chart…

Competitive Landscape

PathAI: regional expansion

Proscia: premium pricing

Aiforia: innovation pipeline

Deep Bio: OEM tie-ups

Hologic: vertical integration

Dipath: local manufacturing

Key AI in Digital Pathology Companies17 items

PathAI

Proscia

Aiforia

Deep Bio

Hologic

Dipath

iDeepwise

LBP

F.Q pathtech

CellaVision

AIRA Matrix

Syntropy

Indica Labs

DoMore Diagnostics

Mindpeak

Evidium

Segments

Market Ecosystem

Technology providers — develop AI algorithms and digital pathology platforms

System integrators / EPCs — integrate AI solutions with existing pathology systems

Distributors / channel partners — provide sales and marketing support

Service providers / after-sales — offer training, maintenance, and support services

End users / buyers — healthcare providers and pathologists utilizing AI in digital pathology

Regulators/standards bodies — establish guidelines and standards for AI in digital pathology

Data/analytics providers — supply data and analytics to support AI model development

Recent Industry Insights

Analyst Overview

Table of Contents